TV Risks Losing Pharma Ad Price 'Premiums,' Guideline Data Predicts

Not only are billions of dollars of pharmaceutical direct-to-consumer TV/CTV advertising dollars at risk from the Trump Administration’s recent effort to stop DTC advertising, but major “pricing premiums” as well, media research company Guideline finds.

Direct-to-consumer (DTC) cost-per-thousand viewer pricing (CPM) is 35% higher than averages for all advertising categories …

Next story loading loading..

Discover Our Publications